In the US, Pradaxa (dabigatran systemic) is a member of the drug class thrombin inhibitors and is used to treat Deep Vein Thrombosis, Prevention of Thromboembolism in Atrial Fibrillation and Pulmonary Embolism.
Ingredient matches for Pradaxa
Dabigatran is reported as an ingredient of Pradaxa in the following countries:
Dabigatran etexilate (a derivative of Dabigatran) is reported as an ingredient of Pradaxa in the following countries:
- Hong Kong
- New Zealand
- South Africa
Dabigatran etexilate mesilate (a derivative of Dabigatran) is reported as an ingredient of Pradaxa in the following countries:
- Croatia (Hrvatska)
- Czech Republic
- Russian Federation
- United Kingdom
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.